Previ Novartis

Previ Novartis

Previ Novartis was established in 1977 as a closed complementary social security entity. Its primary sponsor remains Novartis Biociências S.A., with Sandoz do Brasil having withdrawn in 2025. The fund operates under Brazilian pension regulations and serves plan participants employed by its sponsors. The portfolio spans private equity, venture capital, private credit, and multimarket strategies. Confirmed holdings include Signal Capital III FIP, Domo Ventures Fund 2 FIP, Captalys Orion FIC FIM CP, and SPX Nimitz Estruturado FIC FIM, all accessed through Previ Novartis FIF CIC Mult. Public positions cover Brazilian equity funds such as Oceana Valor FIA and Absoluto Partners Inst. II FIA plus BlackRock iShares S&P 500 ETF exposure. Allocations remain concentrated in Brazil with selective international fixed income and equity holdings. The fund reports 279.67 million USD in assets. It maintains memberships in Abrapp and APEP. Service providers include TAG Investimentos as investment advisor, Itaú Unibanco as custodian, and KPMG as external auditor. No additional offices are disclosed. Previ Novartis functions as a sponsor-tied pension vehicle rather than an independent family office or asset manager. Investment decisions route through designated administrators and external advisors under Brazilian regulatory oversight, with limited public detail on co-investment or direct deal activity.